Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients

por Gatell, Josep M, Morales-Ramirez, Javier O, Hagins, Debbie P, Thompson, Melanie, Keikawus, Arasteh, Hoffmann, Christian, Rugina, Sorin, Osiyemi, Olayemi, Escoriu, Simona, Dretler, Robin, Harvey, Charlotte, Xu, Xia, Teppler, Hedy
Publicado 2014

636. A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Quadrivalent Dengue Vaccine (V181)

por Russell, Kevin, Rupp, Richard E, Morales-Ramirez, Javier O, Diaz-Perez, Clemente, Andrews, Charles P, Lee, Andrew W, Finn, Tyler S, Cox, Kara, Russell, Amy Falk, Schaller, Margaret M, Martin, Jason C, Hyatt, Donna M, Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann
Publicado 2021

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus...

por Russell, Kevin L., Rupp, Richard E., Morales-Ramirez, Javier O., Diaz-Perez, Clemente, Andrews, Charles P., Lee, Andrew W., Finn, Tyler S., Cox, Kara S., Falk Russell, Amy, Schaller, Margaret M., Martin, Jason C., Hyatt, Donna M., Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann G.
Publicado 2022

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

por Bauer, Kristen, Esquilin, Ines O., Cornier, Alberto Santiago, Thomas, Stephen J., Quintero del Rio, Ana I., Bertran-Pasarell, Jorge, Morales Ramirez, Javier O., Diaz, Clemente, Carlo, Simon, Eckels, Kenneth H., Tournay, Elodie, Toussaint, Jean-Francois, De La Barrera, Rafael, Fernandez, Stefan, Lyons, Arthur, Sun, Wellington, Innis, Bruce L.
Publicado 2015